Maintenance of T cell homeostasis is critical for normal functioning of the immune system. After thymocyte selection, T cells enter the peripheral lymphoid organs and are maintained there as na?ve cells. Transient disruption of homeostasis occurs when na?ve T cells undergo antigen-driven expansion and acquire effector functions. Effector T cells then either undergo apoptosis (i.e., contraction at the population level) or survive to become memory cells. This process is crucial: it resets T cell homeostasis, promotes protective immunity, and limits autoimmunity. While both pathways of apoptosis (death receptor and Bcl-2 regulated) can affect T cell homeostasis, recent data point to the Bcl-2-regulated pathway, under dynamic regulation by common gamma chain cytokines, as being critical for T cell homeostasis in vivo. Bim is a non- redundant, pro-apoptotic BH-3-containing molecule critical for limiting survival of na?ve, effector, and to a lesser extent memory T cells. However, the mechanism(s) by which effector T cells survive and enter the memory compartment remain unclear. Such knowledge is crucial for our ability to therapeutically manipulate the metamorphosis of effector T cells to memory T cells. We have found that as cells transition through stages of activation, the anti-apoptotic Bcl-2 family members critical for combating Bim appear to change. In na?ve and resting memory T cells, Bcl-2 is critical to antagonize Bim and promote survival. In situations where Bcl-2 is decreased or absent, Mcl-1 likely antagonizes Bim, but does so less efficiently than Bcl-2. Collectively, these new preliminary data suggest a model in which cytokine-driven signals through Stat5 to Bcl-2 and/or Mcl-1 modulate susceptibility of effector T cells to Bim-mediated death. A testable prediction of this model is that cytokine-driven antagonism of Bim should drive effector T cell survival and enhance pathogen clearance. Experiments in this proposal will test three interrelated hypotheses: (i) Mcl-1 antagonizes Bim in effector T cells when Bcl-2 levels are low (ii) depending upon the cytokine milieu Stat5 signaling to Bcl-2 and/ or Mcl-1 is critical for survival of effector T cells in vivo;and (iii) enhancement of cytokine availability can lead to increased effector T cell survival and pathogen clearance. The long-term goal of this research is to identify molecular targets that could be exploited therapeutically to enhance T cell survival (i.e. to improve vaccination) or to decrease T cell survival (i.e. suppress autoimmune disease or transplant rejection).
Maintenance of T cell homeostasis is critical for normal functioning of the immune system. After an infection, the majority of T cells that have fought the infection die, while some remain, become memory cells, and provide protection from re-infection. Mechanisms that control the death/survival of these T cells remain unclear, but are critical to our understanding of protective immunity. We have found that a single molecule Bim limits the numbers of memory T cells in mice. This proposal explores mechanism(s) by which T cells normally combat Bim and how they can be manipulated to combat Bim to improve immunologic memory.
|Sena, Laura A; Li, Sha; Jairaman, Amit et al. (2013) Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38:225-36|
|Tripathi, P; Koss, B; Opferman, J T et al. (2013) Mcl-1 antagonizes Bax/Bak to promote effector CD4(+) and CD8(+) T-cell responses. Cell Death Differ 20:998-1007|
|Tripathi, Pulak; Kurtulus, Sema; Wojciechowski, Sara et al. (2010) STAT5 is critical to maintain effector CD8+ T cell responses. J Immunol 185:2116-24|
|Kurtulus, Sema; Tripathi, Pulak; Opferman, Joseph T et al. (2010) Contracting the 'mus cells'--does down-sizing suit us for diving into the memory pool? Immunol Rev 236:54-67|
|Unsinger, Jacqueline; McGlynn, Margaret; Kasten, Kevin R et al. (2010) IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 184:3768-79|
|Morris, Suzanne C; Heidorn, Stephanie M; Herbert, De'Broski R et al. (2009) Endogenously produced IL-4 nonredundantly stimulates CD8+ T cell proliferation. J Immunol 182:1429-38|
|Reckling, Stacie; Divanovic, Senad; Karp, Christopher L et al. (2008) Proapoptotic Bcl-2 family member Bim promotes persistent infection and limits protective immunity. Infect Immun 76:1179-85|
|Lages, Celine S; Suffia, Isabelle; Velilla, Paula A et al. (2008) Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 181:1835-48|
|Hildeman, David; Jorgensen, Trine; Kappler, John et al. (2007) Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol 19:516-21|
|DeKoter, Rodney P; Schweitzer, Brock L; Kamath, Meghana B et al. (2007) Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells. J Biol Chem 282:14194-204|
Showing the most recent 10 out of 14 publications